AEON Biopharma, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q4 2020 to Q2 2023
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
AEON Biopharma, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q4 2020 to Q2 2023.
- AEON Biopharma, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2023 was 0.21 pure, unchanged year-over-year.
- AEON Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- AEON Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)